| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1068965860 |
| P356 | DOI | 10.2119/MOLMED.2016.00140 |
| P932 | PMC publication ID | 5072414 |
| P698 | PubMed publication ID | 27341515 |
| P2093 | author name string | Markus H Gräler | |
| Hans-Peter Deigner | |||
| Clemens L Bockmeyer | |||
| Ralf A Claus | |||
| Gordon P Otto | |||
| Alexander C Bunck | |||
| Ha-Yeun Chung | |||
| Daniel C Hupe | |||
| Marcel Sprenger | |||
| Michael J Dorer | |||
| P2860 | cites work | A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 |
| Acid and neutral sphingomyelinases: roles and mechanisms of regulation | Q28253522 | ||
| Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 | ||
| Innate immune recognition of lipopolysaccharide by endothelial cells | Q32106820 | ||
| The role of lipid rafts in LPS-induced signaling in a macrophage cell line | Q33215392 | ||
| Substantial performance discrepancies among commercially available kits for reverse transcription quantitative polymerase chain reaction: a systematic comparative investigator-driven approach. | Q54437313 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference | Q55879451 | ||
| Compartmentalization of ceramide signaling: physical foundations and biological effects | Q57348607 | ||
| Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor | Q61757052 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 | ||
| Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis | Q73644309 | ||
| The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid | Q79133370 | ||
| Role of ceramide in membrane protein organization investigated by combined AFM and FCS | Q80886961 | ||
| Plasma platelet-activating factor acetylhydrolase activity in critically ill patients | Q81824025 | ||
| The Role of Polyamines in the Neutralization of Bacteriophage Deoxyribonucleic Acid | Q114755456 | ||
| Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways | Q38256655 | ||
| Endothelial barrier dysfunction in septic shock | Q38270705 | ||
| Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase | Q39096709 | ||
| Acid sphingomyelinase is required for lipid Raft TLR4 complex formation | Q40155108 | ||
| New insights on the use of desipramine as an inhibitor for acid ceramidase | Q40244998 | ||
| Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection | Q40287482 | ||
| Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells | Q40506997 | ||
| Fluorescent, short-chain C6-NBD-sphingomyelin, but not C6-NBD-glucosylceramide, is subject to extensive degradation in the plasma membrane: implications for signal transduction related to cell differentiation | Q41317620 | ||
| Internalization and sorting of a fluorescent analogue of glucosylceramide to the Golgi apparatus of human skin fibroblasts: utilization of endocytic and nonendocytic transport mechanisms | Q41469121 | ||
| Effect of multiple cytokines plus bacterial endotoxin on glucose and nitric oxide production by cultured hepatocytes | Q42983028 | ||
| Molecular mechanisms of ceramide-mediated CD95 clustering | Q43642943 | ||
| High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates. | Q43969278 | ||
| HPLC separation and ultrasensitive optical quantification of ceramide species applying 7-(diethylamino)coumarin-3-carbonyl azide derivatisation | Q46765984 | ||
| GM1 and GD1a gangliosides modulate toxic and inflammatory effects of E. coli lipopolysaccharide by preventing TLR4 translocation into lipid rafts. | Q46799613 | ||
| Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts | Q46842891 | ||
| Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. | Q51431246 | ||
| Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis | Q33368853 | ||
| Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression | Q33510915 | ||
| Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity | Q33957717 | ||
| Compartmentalization of ceramide signaling: physical foundations and biological effects | Q33980632 | ||
| The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. | Q34057044 | ||
| Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis | Q34086900 | ||
| Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications | Q34117398 | ||
| Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. | Q34285232 | ||
| Sepsis: current dogma and new perspectives | Q34415915 | ||
| Acid sphingomyelinase serum activity predicts mortality in intensive care unit patients after systemic inflammation: a prospective cohort study | Q34482934 | ||
| Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research | Q34503665 | ||
| Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression | Q34682367 | ||
| Mechanisms of sepsis-induced organ dysfunction | Q34703764 | ||
| Ceramide: second messenger or modulator of membrane structure and dynamics? | Q34984863 | ||
| Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis | Q35607603 | ||
| Ceramide, membrane rafts and infections | Q35740198 | ||
| Anti-inflammatory properties of desipramine and fluoxetine | Q35807992 | ||
| Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice | Q35913691 | ||
| Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C. | Q35946802 | ||
| Plasma Membrane Repair Is Regulated Extracellularly by Proteases Released from Lysosomes. | Q35974137 | ||
| Dynamical systems approach to endothelial heterogeneity | Q36104888 | ||
| Role of tethering factors in secretory membrane traffic. | Q36336697 | ||
| Physiological and pathophysiological aspects of ceramide | Q36341274 | ||
| Epidemiology of severe sepsis around the world | Q36513099 | ||
| Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms | Q36724276 | ||
| Endothelium as a therapeutic target in sepsis | Q36789489 | ||
| The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases | Q36879383 | ||
| Inflammation, endothelium, and coagulation in sepsis | Q37011058 | ||
| Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement | Q37134785 | ||
| ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. | Q37188851 | ||
| Intracellular transport and metabolism of sphingomyelin | Q37673615 | ||
| Approaching clinical reality: markers for monitoring systemic inflammation and sepsis. | Q37701478 | ||
| Small molecule inhibitors of acid sphingomyelinase. | Q37760683 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| systemic inflammation | Q7663815 | ||
| P577 | publication date | 2016-06-15 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Acid sphingomyelinase promotes endothelial stress response in systemic inflammation and sepsis | |
| P478 | volume | 22 |
| Q41993606 | Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver |
| Q57463140 | Acid Sphingomyelinase Inhibition Stabilizes Hepatic Ceramide Content and Improves Hepatic Biotransformation Capacity in a Murine Model of Polymicrobial Sepsis |
| Q33624807 | Adjustment of Dysregulated Ceramide Metabolism in a Murine Model of Sepsis-Induced Cardiac Dysfunction |
| Q90198960 | Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro |
| Q59353222 | Inflammatory cytokine expression in patients with sepsis at an intensive care unit |
Search more.